• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳头瘤病毒在头颈部鳞状细胞癌中作为具有临床重要意义的生物标志物的作用不断演变。

Evolving role of human papillomavirus as a clinically significant biomarker in head and neck squamous cell carcinoma.

机构信息

a Department of Head and Neck-Endocrine Oncology , Moffitt Cancer Center , Tampa , FL , USA.

b Department of Anatomic Pathology , Moffitt Cancer Center , Tampa , FL , USA.

出版信息

Expert Rev Mol Diagn. 2019 Jan;19(1):63-70. doi: 10.1080/14737159.2019.1559056. Epub 2018 Dec 21.

DOI:10.1080/14737159.2019.1559056
PMID:30575409
Abstract

: The majority of squamous cell carcinoma (SCC) of the oropharynx, one of the sites within the head and neck region, is now associated with high-risk human papillomavirus (HPV) in North America. Several modalities are available to determine the HPV status, however, the understanding of each assay in its application and limitations is essential for accurate interpretation and appropriate utilization of results in management of these patients. : This expert review will cover the role of HPV in head and neck squamous cell carcinoma (HNSCC), indications for HPV testing, HPV detection methods in tumors, saliva and serum, and exploiting HPV status as a prognostic biomarker of clinical outcome in HNSCC. : The HPV status is the most significant diagnostic and prognostic biomarker in HNSCC, specifically in the oropharynx. Research underway is currently delineating the role of HPV and p16 testing in non-oropharyngeal sites. While the feasibility of non-invasive serum and saliva testing for HPV detection has been established, the clinical application of these assays is still evolving.

摘要

口咽鳞状细胞癌(SCC)是头颈部区域的一种癌症,大多数口咽 SCC 现在与北美高危型人乳头瘤病毒(HPV)有关。有几种方法可以确定 HPV 状态,但了解每种检测方法的应用和局限性对于准确解释和正确利用这些患者的检测结果至关重要。

本专家综述将涵盖 HPV 在头颈部鳞状细胞癌(HNSCC)中的作用、HPV 检测的适应证、肿瘤、唾液和血清中的 HPV 检测方法,以及利用 HPV 状态作为 HNSCC 临床结果的预后生物标志物。

HPV 状态是 HNSCC 中最重要的诊断和预后生物标志物,特别是在口咽部位。目前正在进行的研究正在描绘 HPV 和 p16 检测在非口咽部位的作用。虽然已经证实了非侵入性血清和唾液 HPV 检测的可行性,但这些检测方法的临床应用仍在不断发展。

相似文献

1
Evolving role of human papillomavirus as a clinically significant biomarker in head and neck squamous cell carcinoma.人乳头瘤病毒在头颈部鳞状细胞癌中作为具有临床重要意义的生物标志物的作用不断演变。
Expert Rev Mol Diagn. 2019 Jan;19(1):63-70. doi: 10.1080/14737159.2019.1559056. Epub 2018 Dec 21.
2
HPV-related squamous cell carcinoma of the head and neck: An update on testing in routine pathology practice.人乳头瘤病毒相关的头颈部鳞状细胞癌:常规病理学实践中的检测更新
Semin Diagn Pathol. 2015 Sep;32(5):344-51. doi: 10.1053/j.semdp.2015.02.013. Epub 2015 Feb 4.
3
North-American survey on HPV-DNA and p16 testing for head and neck squamous cell carcinoma.北美关于头颈部鳞状细胞癌的人乳头瘤病毒DNA(HPV-DNA)和p16检测的调查
Oral Oncol. 2014 Oct;50(10):942-6. doi: 10.1016/j.oraloncology.2014.07.004. Epub 2014 Aug 2.
4
Cytokeratin 7 in Oropharyngeal Squamous Cell Carcinoma: A Junctional Biomarker for Human Papillomavirus-Related Tumors.口咽鳞状细胞癌中的细胞角蛋白7:一种与人乳头瘤病毒相关肿瘤的交界性生物标志物。
Cancer Epidemiol Biomarkers Prev. 2017 May;26(5):702-710. doi: 10.1158/1055-9965.EPI-16-0619. Epub 2017 Jan 12.
5
Low prevalence of transcriptionally active human papilloma virus in Indian patients with HNSCC and leukoplakia.印度头颈部鳞状细胞癌和白斑患者中转录活性人乳头瘤病毒的低流行率。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 Nov;122(5):609-618.e7. doi: 10.1016/j.oooo.2016.06.006. Epub 2016 Jun 22.
6
Role of cytology in the diagnosis and management of HPV-associated head and neck carcinoma.细胞学在人乳头瘤病毒相关头颈癌诊断与管理中的作用。
Acta Cytol. 2013;57(2):117-26. doi: 10.1159/000346715. Epub 2013 Feb 28.
7
Molecular Diagnostics in Human Papillomavirus-Related Head and Neck Squamous Cell Carcinoma.人乳头瘤病毒相关头颈部鳞状细胞癌的分子诊断。
Cells. 2020 Feb 22;9(2):500. doi: 10.3390/cells9020500.
8
Antibodies against human papillomaviruses as diagnostic and prognostic biomarker in patients with neck squamous cell carcinoma from unknown primary tumor.针对不明原发灶颈部鳞癌患者的人乳头瘤病毒抗体作为诊断和预后生物标志物。
Int J Cancer. 2018 Apr 1;142(7):1361-1368. doi: 10.1002/ijc.31167. Epub 2017 Dec 4.
9
HPV-related carcinomas of the head and neck: morphologic features, variants, and practical considerations for the surgical pathologist.头颈部人乳头瘤病毒相关癌:形态学特征、变异型及外科病理学家的实践考量
Virchows Arch. 2017 Aug;471(2):295-307. doi: 10.1007/s00428-017-2118-y. Epub 2017 Apr 17.
10
p16 expression is of prognostic and predictive value in oropharyngeal cancers independent of human papillomavirus status: a Hungarian study.p16表达在口咽癌中具有独立于人类乳头瘤病毒状态的预后和预测价值:一项匈牙利的研究。
Eur Arch Otorhinolaryngol. 2017 Apr;274(4):1959-1965. doi: 10.1007/s00405-016-4412-8. Epub 2016 Dec 20.

引用本文的文献

1
Development of human papillomavirus and its detection methods (Review).人乳头瘤病毒的发展及其检测方法(综述)
Exp Ther Med. 2024 Jul 31;28(4):382. doi: 10.3892/etm.2024.12671. eCollection 2024 Oct.
2
Biplex quantitative PCR to detect transcriptionally active human papillomavirus 16 from patient saliva.双靶标实时定量 PCR 法检测患者唾液中转录活性的人乳头瘤病毒 16。
BMC Cancer. 2024 Apr 10;24(1):442. doi: 10.1186/s12885-024-12125-9.
3
Feline oral squamous cell carcinoma and papillomavirus: is it time to walk the path of human oncology?
猫口腔鳞状细胞癌与乳头瘤病毒:是时候走上人类肿瘤学的道路了吗?
Front Vet Sci. 2023 May 17;10:1148673. doi: 10.3389/fvets.2023.1148673. eCollection 2023.
4
HPV Enhances HNSCC Chemosensitization by Inhibiting SERPINB3 Expression to Disrupt the Fanconi Anemia Pathway.人乳头瘤病毒通过抑制丝氨酸蛋白酶抑制剂B3的表达来破坏范可尼贫血途径,从而增强头颈部鳞状细胞癌的化疗敏感性。
Adv Sci (Weinh). 2022 Nov 16;10(1):e2202437. doi: 10.1002/advs.202202437.
5
Concordance of p16 and E6*I mRNA among HPV-DNA-Positive Oropharyngeal, Laryngeal, and Oral Cavity Carcinomas from the ICO International Study.来自国际癌症研究机构(ICO)国际研究的HPV-DNA阳性口咽癌、喉癌和口腔癌中p16与E6*I mRNA的一致性
Cancers (Basel). 2022 Aug 4;14(15):3787. doi: 10.3390/cancers14153787.
6
Liquid Biopsy in Squamous Cell Carcinoma of the Esophagus and of the Head and Neck.食管癌及头颈部鳞状细胞癌的液体活检
Front Med (Lausanne). 2022 Apr 29;9:827297. doi: 10.3389/fmed.2022.827297. eCollection 2022.
7
Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.复发和/或转移性头颈部鳞状细胞癌中同步西妥昔单抗和纳武利尤单抗的多机构 II 期临床试验结果。
Clin Cancer Res. 2022 Jun 1;28(11):2329-2338. doi: 10.1158/1078-0432.CCR-21-3849.
8
Recent Advances and Future Directions in Clinical Management of Head and Neck Squamous Cell Carcinoma.头颈部鳞状细胞癌临床管理的最新进展与未来方向
Cancers (Basel). 2021 Jan 18;13(2):338. doi: 10.3390/cancers13020338.
9
Circulating Tumour Cell Expression of Immune Markers as Prognostic and Therapeutic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.循环肿瘤细胞免疫标志物表达对头颈部鳞状细胞癌预后和治疗的生物标志物:系统评价和荟萃分析。
Int J Mol Sci. 2020 Nov 3;21(21):8229. doi: 10.3390/ijms21218229.